Frank Yocca Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

BTAI Quotes by TradingView

Frank Yocca is Chief Scientific Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 1,941 shares of BTAI, which is worth approximately $3,396. The most recent transaction as insider was on Feb 16, 2021, when has been sold 15,000 shares (Common Stock) at a price of $58.53 per share, resulting in proceeds of $877,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.94K
3.63% 3M change
85.59% 12M change
Total Value Held $3,396

Frank Yocca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2021
SELL
Open market or private sale
$877,950 $58.53 p/Share
15,000 Reduced 16.97%
73,397 Common Stock
Jan 25 2021
SELL
Open market or private sale
$721,050 $48.07 p/Share
15,000 Reduced 14.51%
88,397 Common Stock
Jan 25 2021
BUY
Exercise of conversion of derivative security
$6,150 $0.41 p/Share
15,000 Added 12.67%
103,397 Common Stock
FY

Frank Yocca

Chief Scientific Officer
New Haven, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTAI